Ninth Circuit judge questions generic drugmakers on imminent harm
Judge Andrew Hurwitz of the US Court of Appeals for the Ninth Circuit has asked generic drugmakers why they need to block a California law restricting pay-for-delay settlements if they do not plan to enter into such agreements.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10